As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort.

Christopher Alexander HinzeRainer EhmannMargret JandlKatrin MilgerOlaf SchmidtChristian SchulzDirk SkowaschTobias WelteRoland BuhlEckard HamelmannMarco IdzkoChristian TaubeStephanie KornHendrik Suhling

Published in: ERJ open research (2024)

After the GINA update in 2019, the proportion of SMART therapy increased with evidence for better disease control in SMART patients compared to SABA alone https://bit.ly/3SSPX1C.

Keyphrases

low dose
end stage renal disease
ejection fraction
chronic kidney disease
chronic obstructive pulmonary disease
newly diagnosed
peritoneal dialysis
prognostic factors
cystic fibrosis
stem cells
lung function
patient reported outcomes
mesenchymal stem cells
cell therapy